JP2017537057A - 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 - Google Patents

胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 Download PDF

Info

Publication number
JP2017537057A
JP2017537057A JP2017516161A JP2017516161A JP2017537057A JP 2017537057 A JP2017537057 A JP 2017537057A JP 2017516161 A JP2017516161 A JP 2017516161A JP 2017516161 A JP2017516161 A JP 2017516161A JP 2017537057 A JP2017537057 A JP 2017537057A
Authority
JP
Japan
Prior art keywords
cells
placental
isolated
cell
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017516161A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017537057A5 (enExample
Inventor
エー．フィスクコフ スティーブン
エー．フィスクコフ スティーブン
チトカラ デネシュ
チトカラ デネシュ
ヘルツベルグ ウリ
ヘルツベルグ ウリ
ジャンコビク ウラジミール
ジャンコビク ウラジミール
Original Assignee
アントフロゲネシス コーポレーション
アントフロゲネシス コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アントフロゲネシス コーポレーション, アントフロゲネシス コーポレーション filed Critical アントフロゲネシス コーポレーション
Publication of JP2017537057A publication Critical patent/JP2017537057A/ja
Publication of JP2017537057A5 publication Critical patent/JP2017537057A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2017516161A 2014-09-26 2015-09-25 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 Pending JP2017537057A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201462056008P 2014-09-26 2014-09-26
US62/056,008 2014-09-26
US201562145551P 2015-04-10 2015-04-10
US62/145,551 2015-04-10
US201562151726P 2015-04-23 2015-04-23
US62/151,726 2015-04-23
US201562170757P 2015-06-04 2015-06-04
US62/170,757 2015-06-04
US201562220620P 2015-09-18 2015-09-18
US62/220,620 2015-09-18
PCT/US2015/052276 WO2016049485A1 (en) 2014-09-26 2015-09-25 Treatment of diabetic foot ulcer using placental stem cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020143608A Division JP2021001178A (ja) 2014-09-26 2020-08-27 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療

Publications (2)

Publication Number Publication Date
JP2017537057A true JP2017537057A (ja) 2017-12-14
JP2017537057A5 JP2017537057A5 (enExample) 2018-11-15

Family

ID=55582072

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017516161A Pending JP2017537057A (ja) 2014-09-26 2015-09-25 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療
JP2020143608A Withdrawn JP2021001178A (ja) 2014-09-26 2020-08-27 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療
JP2022143365A Pending JP2022184911A (ja) 2014-09-26 2022-09-09 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020143608A Withdrawn JP2021001178A (ja) 2014-09-26 2020-08-27 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療
JP2022143365A Pending JP2022184911A (ja) 2014-09-26 2022-09-09 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療

Country Status (4)

Country Link
US (1) US20170290861A1 (enExample)
EP (1) EP3197467A4 (enExample)
JP (3) JP2017537057A (enExample)
WO (1) WO2016049485A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113116933A (zh) * 2021-04-26 2021-07-16 河北医科大学第四医院 一种防治糖尿病足的干细胞组合物及其应用
CN114404590A (zh) * 2022-01-24 2022-04-29 四川大学华西医院 TGF-β抑制剂在制备治疗糖尿病足的药物中的用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010505857A (ja) * 2006-10-06 2010-02-25 アントフロゲネシス コーポレーション ヒト胎盤コラーゲン組成物、並びにそれらの製造方法及び使用方法
WO2012092458A2 (en) * 2010-12-30 2012-07-05 Anthrogenesis Corporation Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2556145T3 (pl) * 2010-04-07 2017-02-28 Anthrogenesis Corporation Angiogeneza z zastosowaniem łożyskowych komórek macierzystych

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010505857A (ja) * 2006-10-06 2010-02-25 アントフロゲネシス コーポレーション ヒト胎盤コラーゲン組成物、並びにそれらの製造方法及び使用方法
WO2012092458A2 (en) * 2010-12-30 2012-07-05 Anthrogenesis Corporation Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BIOCHEM.BIOPHYS.RES.COMMUN.,2013,438(2),P.410-419, JPN6019033085, ISSN: 0004256130 *

Also Published As

Publication number Publication date
WO2016049485A1 (en) 2016-03-31
US20170290861A1 (en) 2017-10-12
EP3197467A1 (en) 2017-08-02
EP3197467A4 (en) 2018-05-23
JP2022184911A (ja) 2022-12-13
JP2021001178A (ja) 2021-01-07

Similar Documents

Publication Publication Date Title
US20120171161A1 (en) Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
JP2018161133A (ja) 胎盤幹細胞を用いる血管形成
US20210230537A1 (en) Angiogenesis using stimulated placental stem cells
JP2022184911A (ja) 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療
US20230302058A1 (en) Treatment of lymphedema and related conditions using placental adherent cells
JP2021038229A (ja) 急性腎損傷の治療における胎盤幹細胞の使用
JP2023171769A (ja) 胎盤細胞を使用した糖尿病性末梢神経障害の処置
HK40058728A (en) Treatment of diabetic peripheral neuropathy using placental cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180921

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180921

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180928

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190827

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191122

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200428

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20200827

C116 Written invitation by the chief administrative judge to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C116

Effective date: 20200908

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20200908

C27A Decision to dismiss

Free format text: JAPANESE INTERMEDIATE CODE: C2711

Effective date: 20201027

C032 Notice prior to dismissal

Free format text: JAPANESE INTERMEDIATE CODE: C032

Effective date: 20201201

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20201201